Rigosertib is a multi-kinase inhibitor and selective anticancer compound that induces cell apoptosis by inhibiting PI3K/Akt pathway, promoting phosphorylation of histone H2AX and inducing G2/M phase arrest in the cell cycle. Rigosertib is a selective non-ATP-competitive PLK1 inhibitor.
- Size: 1mg
- Purity: ≥98%
- Molecular Formula: C 2 1 H 2 5 NO 8 S
- Molecular Weight: 451.49
- Physical State: Solid
- Storage: Powder:-20℃, 2 years
- Brand: Saint Michael
- Catalogue No.: IR2440-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review